Current knowledge summarized about SARS-CoV-2 infection and associated CV manifestations/complications in children, young adults
Cardiac Complications Up After SARS-CoV-2 Infection Versus Vaccines
Incidence of cardiac outcomes after mRNA COVID-19 vaccination highest in males aged 12 to 17 years, but risk 1.8 to 5.6 times higher after infection
2019 to 2020 Saw Risk-Linked Deaths From Heart Disease, Stroke Up
Highest risk-associated increases were seen in non-Hispanic Black people followed by Hispanics, non-Hispanic Asian or Pacific Islanders
ACC Offers Guidance on Cardiovascular Sequelae of COVID-19
Guidelines address myocarditis and other types of myocardial involvement, postacute sequelae of SARS-CoV-2, and return to exercise
Congenital Heart Defect May Up Risk for Critical COVID-19 Illness
Among patients with congenital heart defects, critical COVID-19 outcomes linked to having comorbidities, male sex, age 50 to 64 years
Long-Lasting Cardiovascular Burden Seen After COVID-19
Increased risk for incident cardiovascular disease also observed among those not hospitalized during acute phase
Four in 10 Adults Report Heart Symptoms During the Pandemic
And, one in four COVID-19 survivors says the virus impacted their heart health
Social Isolation, Loneliness Up Risk of New CVD in Older Women
Findings independent of each other, with an even stronger effect seen for women with high levels of social isolation and loneliness
Cardiac Outcomes Good for Children With COVID-19-Related MIS-C
All deformation parameters on echocardiogram recovered within first week, including LV global longitudinal strain, peak left atrial strain
Myocarditis, Myopericarditis Risk Up After SARS-CoV-2 Vaccination
But absolute rates of myocarditis or myopericarditis after mRNA COVID-19 vaccination low, even in younger age groups